In the context of real-world evidence, a registry is a collection of data on a particular disease, medical condition, or treatment that is recorded over time. A registry-based study, on the other hand, is a research study that uses data from a registry to evaluate the safety or effectiveness of a particular treatment or medical intervention.
A registry is typically created to collect data on a particular population, such as patients with a specific medical condition or those who have been treated with a particular medication. The data collected in a registry may be observational or experimental, and can include demographic information, medical history, treatment information, and outcomes.
A registry-based study, on the other hand, is a research study that uses data from a registry to evaluate the safety or effectiveness of a particular treatment or medical intervention. In a registry-based study, researchers analyze the data collected in a registry to answer specific research questions, such as whether a particular treatment is effective in improving patient outcomes, or whether there are any safety concerns associated with a specific medication.
The main difference between a registry and a registry-based study is that a registry is a database of information, while a registry-based study is a research study that uses data from a registry. Registries can be used for a variety of purposes, including monitoring the safety and effectiveness of treatments, tracking disease incidence and prevalence, and identifying gaps in care. Registry-based studies are one way to use the data collected in a registry to generate new knowledge and insights about a particular disease or treatment.
Overall, both registries and registry-based studies are important tools for collecting and analyzing real-world evidence, and can provide valuable information to healthcare providers, patients, and researchers about the safety and effectiveness of medical interventions.
Share this story...
Real World Evidence (RWE) 101 – Ethical Imperatives (CIOMS 2023)
RWE 101 - Ethical Imperatives (CIOMS 2023) Informed decision making with patients typically relies on evidence from clinical trials that describe the likely benefits and toxicities. However, patients treated [...]
Real World Evidence (RWE) 101 – Ethical Imperatives
RWE 101 - Ethical Imperatives Real-world evidence (RWE) refers to the clinical evidence regarding the usage and potential benefits or risks of a product derived from analysis of real-world [...]
Real World Evidence (RWE) 101 – The Importance of Intent
RWE 101 - The Importance of Intent Real-world evidence (RWE) is the clinical evidence about the usage and potential benefits or risks of a product derived from the analysis [...]
Real World Evidence (RWE) 101 – Inspections
RWE 101 - Inspections Real-World Evidence (RWE) can include data from sources such as electronic health records (EHRs), insurance claims and billing activities, patient registries, patient-generated data, and data [...]
Real World Evidence (RWE) 101 – Audits
RWE 101 - Audits A quality assurance auditor in the context of a real-world evidence (RWE) study has several responsibilities, key among them ensuring that all facets of the [...]
Real World Evidence (RWE) 101 – Compliance Maps
RWE 101 - Compliance Maps In the context of multi-country Real-World Evidence (RWE) studies, "Regulatory Compliance Maps" are essentially a detailed representation of the diverse regulatory requirements specific to [...]







